STUDY TO EVALUATE BIOMARKERS OF SENSITIVITY AND RESISTANCE<BR>IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA WHO<BR>ARE TREATED WITH BRENTUXIMAB VEDOTIN
Latest Information Update: 08 Aug 2014
At a glance
- Drugs Brentuximab vedotin (Primary)
- Indications Hodgkin's disease
- Focus Adverse reactions; Biomarker
Most Recent Events
- 08 Aug 2014 New trial record